David Oscier

发表

Exome sequence read depth methods for identifying copy number changes

Andrew Collins, William Tapper, Reuben J. Pengelly, 2015, Briefings Bioinform..

Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms

Paola Guglielmelli, Torsten Haferlach, William Tapper, 2015, Nature Communications.

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

Andrew Collins, Andrew Chase, Nicholas C P Cross, 2009, Nature Genetics.

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.

Lefteris Angelis, Véronique Giudicelli, Marco Montillo, 2015, Blood.

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study.

Lefteris Angelis, Véronique Giudicelli, Marco Montillo, 2014, The Lancet. Haematology.

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.

Li Wang, Luca Malcovati, Mario Cazzola, 2006, Blood.

Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks

Renata Walewska, Christoph Bock, André F. Rendeiro, 2016, Nature Communications.

DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1.

Dan Grandér, David Oscier, J. Lovén, 2009, Experimental cell research.

Chromatin accessibility maps of chronic lymphocytic leukemia identify subtype-specific epigenome signatures and associated transcription regulatory networks

Renata Walewska, Christoph Bock, André F. Rendeiro, 2016 .